Boehringer Ingelheim Philippines Inc (Philippines)

Boehringer Ingelheim (Philippines), Inc. is the Philippine affiliate of Boehringer Ingelheim, a global research-driven pharmaceutical and animal health company. Based in Metro Manila, it is engaged in the marketing, distribution, and regulatory management of innovative human pharmaceuticals and animal health products for the local market. In human health, the company offers prescription medicines in therapeutic areas such as cardiovascular and metabolic diseases, respiratory conditions, oncology, central nervous system disorders, and other specialized indications, as well as selected consumer health products. In animal health, it provides vaccines and pharmaceuticals for companion animals and livestock, supporting veterinarians, farmers, and pet owners. Its operations encompass medical and scientific affairs, pharmacovigilance, sales and marketing, and coordination with local distributors, hospitals, clinics, and pharmacies nationwide. Boehringer Ingelheim Philippines' key assets include its established product portfolio, relationships with healthcare professionals and institutions, and access to the parent company's extensive research and development pipeline. Strategically, the company focuses on bringing globally developed, evidence-based therapies to the Philippine market, improving access to high-quality medicines and vaccines for humans and animals while maintaining strong compliance with local regulatory and ethical standards.